Skip to content

EUKINES Wearable Plantar-Pressure Insole System for Rehabilitation After Total Hip Arthroplasty

Prospective, Randomized, Partially Blinded, Multicenter Non-Inferiority Trial of the EUKINES Wearable Plantar-Pressure Insole Gait-Analysis System for Postoperative Rehabilitation After Primary Total Hip Arthroplasty

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07448792
Acronym
EUKINES
Enrollment
200
Registered
2026-03-04
Start date
2024-12-15
Completion date
2025-11-30
Last updated
2026-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis, Postoperative Rehabilitation, Total Hip Arthroplasty (THA)

Keywords

gait analysis, rehabilitation, plantar-pressure insoles, wearable sensors, printed sensors, biofeedback, telerehabilitation, total hip arthroplasty, mean foot pressure, EUKINES

Brief summary

This study evaluates a wearable plantar-pressure insole system (EUKINES) designed to support gait training during postoperative rehabilitation after primary total hip arthroplasty (THA). The trial will include 200 adults who are randomly assigned to one of four rehabilitation programs: EUKINES with real-time biofeedback, EUKINES without biofeedback, a certified commercial reference system with biofeedback, or standard rehabilitation without any gait-analysis device. All participants will receive a structured 6-week rehabilitation program after THA, and the only differences between groups concern the use of gait-analysis technology and biofeedback. The main outcomes include changes in plantar-pressure-based gait parameters (mean foot pressure and load asymmetry) and standard clinical scores of hip function and symptoms. The study will also monitor safety, device-related events, walking speed, pain, and patient and therapist ratings of usability and satisfaction. The goal is to determine whether rehabilitation supported by the EUKINES insole system is at least as effective and safe as rehabilitation supported by a certified reference system and as standard care, and to explore the feasibility of using low-cost, printed-sensor technology for routine gait assessment and future telerehabilitation.

Detailed description

This is a prospective, randomized, partially blinded, multicenter clinical trial with a non-inferiority design conducted in patients undergoing primary total hip arthroplasty (THA) for advanced osteoarthritis. The study is embedded in the EUKINES project, which develops low-cost, printable pressure sensors and a wearable plantar-pressure insole system intended for scalable clinical rehabilitation and telerehabilitation use. The trial evaluates the clinical performance, safety, and usability of the EUKINES insole system as an adjunct to standard postoperative rehabilitation. Adult patients scheduled for primary THA will be screened according to predefined inclusion and exclusion criteria and enrolled after providing written informed consent. A total of 200 participants will be randomized in blocks to one of four parallel rehabilitation arms: (1) EUKINES with real-time biofeedback, (2) EUKINES without biofeedback (data recording only), (3) a certified commercial reference gait-analysis system with biofeedback, or (4) standard rehabilitation without any gait-analysis device. All participants will follow the same structured 6-week rehabilitation program after surgery, including routine physiotherapy and six additional, approximately 3-hour gait-focused sessions. The content and duration of rehabilitation are equivalent across groups; only the use of gait-analysis devices and biofeedback differs between arms. Outcome assessments will be performed at baseline and during postoperative follow-up. Primary endpoints include changes in plantar-pressure-derived gait parameters such as mean foot pressure and load asymmetry between the operated and non-operated limb, as well as changes in hip-related clinical scores (Harris Hip Score and the 12-item Hip Disability and Osteoarthritis Outcome Score, HOOS-12) and the incidence of adverse events and device-related complications. Secondary outcomes include extended spatiotemporal gait parameters, 10-Meter Walk Test performance, pain intensity and satisfaction with surgery and rehabilitation, and patient and therapist ratings of usability, comfort, and perceived usefulness of the EUKINES and reference systems. All plantar-pressure time-series data will be stored to allow post-hoc derivation of additional gait metrics and exploratory analyses. The study is classified as a low-risk, add-on interventional trial that does not alter standard surgical procedures or baseline postoperative care. Device-assisted rehabilitation sessions are provided as an adjunct to routine practice. The trial is conducted in accordance with the Declaration of Helsinki and Good Clinical Practice, under the oversight of a bioethics committee. By directly comparing the EUKINES prototype with a certified commercial reference system and standard care, the study aims to demonstrate the feasibility and clinical usefulness of an affordable sensor-based gait-analysis platform and to provide a basis for future development of data-driven telerehabilitation and personalized rehabilitation strategies.

Interventions

DEVICECertified reference gait-analysis system

Commercially available, certified plantar-pressure gait-analysis system used according to the manufacturer's recommendations to provide real-time biofeedback on gait parameters during rehabilitation sessions.

DEVICEEUKINES plantar-pressure insole system

Wearable plantar-pressure insole system developed within the EUKINES project, consisting of thin-film printed pressure sensors, shoe-mounted electronic modules, and PC-based software for real-time gait data acquisition and visualization. In the biofeedback arm, real-time feedback on gait parameters is provided during rehabilitation sessions; in the non-biofeedback arm, data are recorded without feedback.

Standard postoperative rehabilitation program after total hip arthroplasty, delivered according to local clinical protocols and including six additional approximately 3-hour gait-focused rehabilitation sessions over 6 weeks, with progressive gait training, balance and coordination exercises, and functional mobility tasks.

Sponsors

Cardinal Stefan Wyszynski University
Lead SponsorOTHER
National Center for Research and Development, Poland
CollaboratorOTHER
Warsaw University of Technology
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome assessors responsible for postoperative follow-up visits and clinical evaluations are blinded to group allocation. Patients, care providers, and rehabilitation staff are aware of the assigned intervention because of the visible use or non-use of gait-analysis devices.

Intervention model description

Four-arm parallel-group trial with patients allocated to EUKINES with biofeedback, EUKINES without biofeedback, a certified reference gait-analysis system with biofeedback, or standard rehabilitation without a gait-analysis device.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older. * Scheduled for primary total hip arthroplasty performed for advanced osteoarthritis or other degenerative hip disease. * Willingness and ability to participate in the 6-week postoperative rehabilitation program and follow-up assessments. * Ability to understand study information and provide written informed consent.

Exclusion criteria

* Coexisting medical conditions that may significantly affect rehabilitation outcomes or gait (e.g., severe neurological disorders, major lower-limb joint trauma, other significant musculoskeletal pathology). * Cognitive impairment or psychiatric conditions that would preclude effective cooperation with the rehabilitation and research team. * Any contraindication to participation in additional gait training sessions or use of the insole-based gait-analysis systems as judged by the treating physician.

Design outcomes

Primary

MeasureTime frameDescription
Change in mean foot pressure (MFP) on the operated limbBaseline (Week 0), Week 3, Week 6 after surgeryMean foot pressure (MFP) is defined as the average plantar pressure across all active sensing regions of the insole during the stance phase of gait, expressed in kilopascals. MFP will be recorded during standardized 10-meter walking trials using the EUKINES and/or reference insole systems, and session-level MFP will be calculated as the mean value across all valid steps. The primary analysis will compare changes in MFP on the operated limb over time and between rehabilitation arms.
Change in load asymmetry between operated and non-operated limbBaseline (Week 0), Week 3, Week 6 after surgeryLoad asymmetry will be quantified using plantar-pressure data from the EUKINES and/or reference insole systems as the difference or ratio between mean foot pressure on the operated and non-operated limb during standardized 10-meter walking trials. Reduced inter-limb asymmetry over time will be interpreted as improved functional load distribution after total hip arthroplasty.
Change in Harris Hip Score (HHS)Baseline (preoperative or immediate postoperative) and Week 6 after surgeryThe Harris Hip Score is a validated clinician-administered scale assessing pain, function, range of motion, and absence of deformity in patients after hip surgery. Total scores range from 0 to 100, with higher scores indicating better hip function. The primary analysis will compare changes in HHS from baseline to Week 6 between rehabilitation arms.
Change in HOOS-12 total scoreBaseline (preoperative or immediate postoperative) and Week 6 after surgeryThe HOOS-12 is a validated 12-item short form of the Hip Disability and Osteoarthritis Outcome Score that assesses pain, function, and quality of life in hip patients. Scores are transformed to a 0-100 scale, with higher scores indicating better outcomes. The main analysis will evaluate changes in HOOS-12 total score from baseline to Week 6, with reference to the minimal clinically important difference of approximately 9-12 points reported in the literature.
Incidence of adverse events and device-related complicationsFrom enrollment through Week 6 after surgerySafety will be assessed by recording all adverse events, device-related complications, skin irritation, falls, or other medical incidents potentially associated with device use or the supplementary rehabilitation sessions. Events will be classified by severity, relationship to the device or intervention, and outcome.

Secondary

MeasureTime frameDescription
Preferred walking speed (10-Meter Walk Test)Baseline, Week 3, Week 6Preferred walking speed over 10 meters will be measured in m/s during standardized 10-Meter Walk Tests; changes over time and between groups will be analyzed.
Change in maximal walking speed (10-Meter Walk Test)Baseline, Week 3, Week 6Maximal walking speed over 10 meters will be measured in m/s during standardized 10-Meter Walk Tests; changes over time and between groups will be analyzed.
Change in spatiotemporal gait parameters derived from plantar-pressure insolesAdditional gait parameters (e.g., cadence, stance and swing phase duration, rollover time) will be derived from plantar-pressure time-series data and analyzed as exploratory secondary outcomes.Baseline, Week 3, Week 6
Change in hip pain intensity (VAS)Baseline, Week 3, Week 6Hip pain will be rated on a visual analogue scale (0-10), with higher scores indicating greater pain; changes over time and between groups will be compared.
Change in patient satisfaction with surgery and rehabilitation measured with a Visual Analogue Scale (VAS)Week 3 and Week 6Patient satisfaction with surgery and postoperative rehabilitation will be assessed using a 100-mm Visual Analogue Scale (VAS) ranging from 0 to 100, where 0 indicates "not satisfied at all" (worst possible satisfaction) and 100 indicates "extremely satisfied" (best possible satisfaction). The VAS score (points, 0-100; higher scores indicate better satisfaction) will be recorded at Week 3 and Week 6 after surgery, and changes over time and between study groups will be compared
Patient-reported usability and comfort of the EUKINES and reference systems (study-specific 15-item Likert-scale questionnaire)Week 3 and Week 6Patient-reported usability and comfort of the EUKINES system and the reference system will be assessed with a study-specific EUKINES Usability and Comfort Questionnaire developed by the investigators, consisting of 15 items rated on a 5-point Likert scale (0 = strongly disagree, 4 = strongly agree). For each system, an overall usability and comfort score will be calculated as the mean of all item scores and expressed in points (range 0-4; higher scores indicate better usability and greater comfort). Scores will be collected at Week 3 and Week 6 after surgery, and changes over time and between study groups will be compared.
Therapist-reported usability and perceived usefulness of the EUKINES and reference systems (study-specific 12-item Likert-scale questionnaire)Throughout the 6-week rehabilitation periodTherapist-reported usability and perceived usefulness of the EUKINES system and the reference system will be assessed with a study-specific EUKINES Therapist Usability and Usefulness Questionnaire developed by the investigators, consisting of 12 items rated on a 5-point Likert scale (0 = strongly disagree, 4 = strongly agree). Two summary scores will be calculated for each system: a usability score and a perceived usefulness score, each expressed in points as the mean of the corresponding items (range 0-4; higher scores indicate better usability or greater perceived usefulness). Scores collected throughout the 6-week rehabilitation period will be analyzed as repeated measures and compared between systems and between study groups.

Countries

Poland

Contacts

PRINCIPAL_INVESTIGATORAndrzej Kotela

Cardinal Stefan Wyszynski University in Warsaw

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026